VCYT
Veracyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.53
−4.79%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.03x
- Debt / EBITDA
- 0.31x
- Net debt / EBITDA
- -2.00x
Liquidity & coverage
- Current ratio
- 9.16x
- Quick ratio
- 8.80x
- Cash ratio
- 7.73x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $512.0M
Cash & dividend
- FCF / debt
- 4.13x
- Cash flow / debt
- 4.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026